Under PARP inhibition, single-strand breaks in DNA are further damaged to double-strand breaks, which can be repaired by homologous recombination mechanisms in normal cells, whereas the double-strand breaks cannot be properly repaired in cancer cells with mutations in breast cancer susceptibility genes (BRCA1 and BRCA2), leading to cell death [3, 5]. Here, PARP1 is linked to cancer.